Why we Love Doctours

Brimstone Hill Capital invested in Doctours because we believe medical travel is undergoing a major shift and the team has shown early proof of real customer demand. We saw founders with rare lived experience who have relied on medical tourism themselves, including moments where it directly impacted the health and safety of their own families.

This firsthand perspective gives them earned insight into the trust gaps and friction patients feel when seeking care abroad. Doctours has already demonstrated that trust, transparency and coordination can be dramatically improved for patients navigating this journey.

Their product simplifies a process that is often overwhelming for individuals making high stakes decisions. The early traction and customer outcomes signaled a service people are willing to adopt quickly. The founding team combines technical depth with genuine domain understanding.
Doctours fits our investment preference for early stage companies solving real inefficiencies through technology.